The aim of this study was to develop a simple, sensitive, accurate, efficient and reproducible Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) method that maintains stability for the simultaneous determination of Miconazole nitrate and metronidazole in vaginal gel formulations. Using a diode array detector at 210 nm, chromatography was conducted on a Zorbax SB-8 column (150 × 4.6 mm, 3.5 μm) under linear elution with a combination of solvent A (water) and solvent B (isopropyl alcohol) as the mobile phase, including a flow rate of 1.0 mL/min. The linearity of metronidazole and Miconazole nitrate exhibited correlation coefficients of 0.9997 and 0.9995, respectively. The limits of detection and quantification were 0.05 μg/mL and 0.42 μg/mL for metronidazole and 0.16 μg/mL and 1.24 μg/mL for Miconazole nitrate. The technique yielded good results, with recovery rates between 98.0% and 102.0% and repeatability of ≤ 2.0%. This method is suitable for routine quality control testing of dosage forms containing these compounds due to its straightforwardness, accuracy and precision. The method's run time is reduced, leading to a lower solvent requirement. The analytical method was developed and validated to comply with ICH guidelines.
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 15261 citations as per Google Scholar report